机构:[1]The George Institute for Global Health, University of Sydney, Australia[2]Department of Epidemiology, Johns Hopkins University, Baltimore, USA[3]Shiga University of Medical Science, Japan[4]School of Public Health, University of Hong Kong, China[5]Xuanwu Hospital, Capital Medical University, Beijing, China首都医科大学宣武医院[6]Department of Preventive Medicine, Yonsei University College of Medicine, Korea[7]Department of Epidemiology and Public Health, University College London, UK[8]Division of Epidemiology and Public Health, University of Minnesota, USA
Background: Multiple studies have examined the relationship between heart rate and mortality; however, there are discrepancies in results. Our aim was to describe the relationship between resting heart rate (RHR) and both major cardiovascular (CV) outcomes, as well as all-cause mortality in the Asia-Pacific region. Design and methods: Individual data from 112,680 subjects in 12 cohort studies were pooled and analysed using Cox models, stratified by study and sex, and adjusted for age and systolic blood pressure. Results: During a mean 7.4 years follow-up, 6086 deaths and 2726 fatal or nonfatal CV events were recorded. There was a continuous, increasing association between having a RHR above approximately 65 beats/min and the risk of both CV and all-cause mortality, yet there was no evidence of associations below this threshold. The hazard ratio (95% CI) comparing the extreme quarters of RHR (80+ v <65 beats/mm) was 1.44 (1.29-1.60) for CV and 1.54 (1.43-1.66) for total mortality. These associations were not materially changed by adjustment for other risk factors and exclusion of the first 2 years of follow-up. Hazard ratios of a similar magnitude were found for ischemic and hemorrhagic stroke, but the hazard ratio for heart failure was higher (2.08, 95% CI 1.07-4.06) and for Coronary Heart Disease (CHD) was lower (1.1 I, 95% CI 0.93-1.31) than for stroke. Conclusions: RHR of above 65 beats/nnin has a strong independent effect on premature mortality and stroke, but a lesser effect on CHD. Lifestyle and pharmaceutical regimens to reduce RHR may be beneficial for people with moderate to high levels of RHR.
基金:
Servier
the Australian National Health and Medical Research Council (NHMRC)(grant number 571281).
第一作者机构:[1]The George Institute for Global Health, University of Sydney, Australia[2]Department of Epidemiology, Johns Hopkins University, Baltimore, USA[*1]The George Institute, PO Box M201, Camperdown, Sydney, New South Wales 2050, Australia.
通讯作者:
通讯机构:[*1]The George Institute, PO Box M201, Camperdown, Sydney, New South Wales 2050, Australia.
推荐引用方式(GB/T 7714):
Mark Woodward,Ruth Webster,Yoshitaka Murakami,et al.The association between resting heart rate, cardiovascular disease and mortality: evidence from 112,680 men and women in 12 cohorts[J].EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY.2014,21(6):719-726.doi:10.1177/2047487312452501.
APA:
Mark Woodward,Ruth Webster,Yoshitaka Murakami,Federica Barzi,Tai-Hing Lam...&Anthony Rodgers.(2014).The association between resting heart rate, cardiovascular disease and mortality: evidence from 112,680 men and women in 12 cohorts.EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY,21,(6)
MLA:
Mark Woodward,et al."The association between resting heart rate, cardiovascular disease and mortality: evidence from 112,680 men and women in 12 cohorts".EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 21..6(2014):719-726